At a glance
ClinicalIndex Comparison RecordN/ACompleted· 40 enrolled
Drug / intervention
Mango +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Mangos to Reduce Cardiometabolic Risk Markers
California State Polytechnic University, Pomona·interventional·Posted Sep 8, 2023·Updated Feb 13, 2025
In Brief
A clinical study evaluating Mango and vanilla wafers for Healthy. Completed, enrolled 40 participants across 1 site.
Detailed Summary
This research study will determine the effects of mango consumption on blood pressure, body weight, dietary nutrient/pattern changes, total cholesterol, LDL-cholesterol, VLDL-cholesterol, triglycerides, and HDL-cholesterol in individuals with moderately elevated blood pressure and/or LDL-cholesterol.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202420252026
First PostedSep 2023
Enrollment StartSep 2023
Primary CompletionSep 2024
TodayJul 2026
First PostedSep 8, 2023
Enrollment StartSep 18, 2023
Primary CompletionSep 12, 2024
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 2.8 years ago
Interventions
Mangoother
The participants will consume the treatment for 16 weeks, followed by a 4-week washout period.
vanilla wafersother
vanilla wafers